U.S. Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute announces the availability of funding for implementation of the Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator-Directed Therapeutics (R41) Small Business Technology Transfer (STTR) Grant. The purpose of this grant is to support the technical development and validation of novel in vitro human cell-based tools for predicting the responses of individual patients to cystic fibrosis transmembrane conductance regulator-directed therapies for cystic fibrosis lung disease. Contractors should refer to Section VII, Agency Contacts, in the . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

RFP | December 3, 2014

Federal Government Announces Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator-Directed Therapeutics (R41) STTR Grant Funding

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member